TICKVALE
>⌘K
NYSE · CIK 0000078003 · PHARMACEUTICAL PREPARATIONS

PFIZER INC

PFE chart by TradingView
P/E 31.9xP/B 1.6xP/SALES 2.2xEV/EBITDA FCF YIELD 7.94%

PRICE HISTORY

LIVE · NYSE
PFE chart by TradingView
REVENUE FY2025 ENDED DEC 2025
$62.6B
EBITDA
FREE CASH FLOW
$9.1B
EPS
$1.36
GROSS MARGIN
74.33%
ROIC
5.18%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET

VALUATION

what you pay for a unit of the business7 CHARTS

P / E RATIO (TTM)

31.9x
+1%
LATEST · Q2 FY26
31.9xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
8.0x76.7x

P / SALES (TTM)

2.2x
-41%
LATEST · Q2 FY26
2.2xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
2.2x6.1x

P / BOOK

1.6x
-48%
LATEST · Q2 FY26
1.6xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
1.5x4.4x

EV / EBITDA (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EV / REVENUE (TTM)

3.1x
-30%
LATEST · Q2 FY26
3.1xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
2.8x7.6x

FCF YIELD (TTM)

7.94%
+1.2pp
LATEST · Q2 FY26
7.94%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
2.95%12.11%

DIVIDEND YIELD (TTM)

7.08%
+3.7pp
LATEST · Q2 FY26
7.08%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
2.66%7.20%

GROWTH

is the business getting bigger5 CHARTS

REVENUE

$15.0B
+15%
LATEST · Q2 FY26
15.0BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EBITDA (DERIVED)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

NET INCOME

$-0.2B
-118%
LATEST · Q2 FY26
-0.2BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EPS (DILUTED)

$-0.04
-120%
LATEST · Q2 FY26
-0.04Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

REVENUE GROWTH YOY

2.60%
-5.3pp
LATEST · Q2 FY26
2.60%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-91.57%520.02%

PROFITABILITY & RETURNS

what survives to the bottom, and what it earns on capital4 CHARTS

FCF MARGIN

2.01%
-31.0pp
LATEST · Q2 FY26
2.01%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-18.20%355.93%

RETURN ON CAPITAL

2.94%
-3.0pp
LATEST · Q2 FY26
2.94%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-1.75%24.22%

RETURN ON EQUITY (TTM)

5.09%
-4.8pp
LATEST · Q2 FY26
5.09%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-2.96%33.61%

MARGIN FUNNEL

every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the business
GROSS MARGIN72.78%
OPERATING MARGIN
NET MARGIN-1.65%
FCF MARGIN2.01%
394.94277.92160.9143.90-73.12GROSSNETFCFQ3 FY16Q3 FY17Q3 FY18Q3 FY19Q3 FY20Q3 FY21Q3 FY22Q3 FY23Q3 FY24Q3 FY25Q2 FY26

CASH & CAPITAL

where the money actually goes5 CHARTS

FREE CASH FLOW

$0.3B
-93%
LATEST · Q2 FY26
0.3BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

STOCK-BASED COMP

$0.2B
+72%
LATEST · Q2 FY26
0.2BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

CAPITAL EXPENDITURE

$0.5B
+23%
LATEST · Q2 FY26
0.5BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

SHARES OUTSTANDING

5.70B
-7%
LATEST · Q2 FY26
5.70BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DIVIDEND / SHARE

$0.86
+153%
LATEST · Q2 FY26
0.86Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

BALANCE SHEET

how much cushion there is3 CHARTS

CASH & EQUIVALENTS

$1.0B
-53%
LATEST · Q2 FY26
1.0BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

TOTAL DEBT

$63.1B
+43%
LATEST · Q2 FY26
63.1BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DEBT / EBITDA (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

OWNERSHIP

10 LARGEST HOLDERS · WHO OWNS THE FLOAT
INSTITUTIONS 70.28%INSIDERS 0.10%OTHER / RETAIL 29.62%3,648 INSTITUTIONAL FILERS
HOLDER% HELDSHARESVALUECHANGE
Blackrock Inc.8.74%498.3M$13.33B+1.1%
Vanguard Capital Management LLC6.48%369.4M$9.89BNEW
State Street Corporation5.29%301.6M$8.07B+0.4%
Geode Capital Management, LLC2.34%133.6M$3.57B+2.6%
Vanguard Portfolio Management LLC2.05%116.7M$3.12BNEW
Fisher Asset Management, LLC1.91%109.1M$2.92B+3.9%
Morgan Stanley1.63%92.7M$2.48B+4.0%
Northern Trust Corporation1.09%62.0M$1.66B-1.9%
Bank Of New York Mellon Corporation1.02%57.9M$1.55B+7.4%
Massachusetts Financial Services Co.0.99%56.6M$1.51B-0.6%
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.